Vectura Group plc is a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. Our goal is to improve patients’ lives and generate value for our stakeholders.
Press releases
27 November 2009Vectura Group plc - Interim Results for the six months ended 30 September 2009
13 November 2009Notice of the date of announcement of the 2009/10 half year results
22 October 2009Update on NVA237 and QVA149 for Chronic Obstructive Pulmonary Disease
Latest press releases
Next events
2-4 March 2010Credit Suisse Global Healthcare Conference, London
16 March 2010
Bank of America/ Merrill Lynch Pan-European Biotech/Medtech Conference
Investor Calendar
